Global artificial intelligence in diabetes management market was estimated to be US$ 218.70 million in 2018 and is expected to reach US$ 3874.52 million by 2027, growing at a CAGR of 37.7% over the forecast period (2019 to 2027). Market participants include Diabnext, DreaMed Diabetes, Ltd., GlucoMe, Hedia, medicsen, Medtronic, Sweetch, TypeZero Technologies, Inc., XBIRD among others.Download...